ID: ALA4861682

Max Phase: Preclinical

Molecular Formula: C26H25BN6O3

Molecular Weight: 480.34

Molecule Type: Unknown

Representations

Canonical SMILES:  Cc1cc2c(NC(=O)CC#N)cccc2n1-c1nc2c(c(NCc3cccc(B(O)O)c3)n1)CCC2

Standard InChI:  InChI=1S/C26H25BN6O3/c1-16-13-20-22(30-24(34)11-12-28)9-4-10-23(20)33(16)26-31-21-8-3-7-19(21)25(32-26)29-15-17-5-2-6-18(14-17)27(35)36/h2,4-6,9-10,13-14,35-36H,3,7-8,11,15H2,1H3,(H,30,34)(H,29,31,32)

Standard InChI Key:  IQOBIILTMFXGDH-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 480.34

Molecular Weight (Monoisotopic): 480.2081

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Zhang Y, Xie X, Wang X, Wen T, Zhao C, Liu H, Zhao B, Zhu Y..  (2021)  Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors.,  38  [PMID:33831696] [10.1016/j.bmc.2021.116114]

Source

Source(1):

• Scientific Literature